Pacific Biosciences of California, Inc. (PACB) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $311.00K; Additional Paid in CapitalUSD $2.72B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-503.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $311.00K; Additional Paid in CapitalUSD $2.71B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-147.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $302.00K; Additional Paid in CapitalUSD $2.70B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $457.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $302.00K; Additional Paid in CapitalUSD $2.69B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $415.00K.
Pacific Biosciences of California, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Split USD | Common Stocks, Including Additional Paid in Capital USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $311.00K | $2.72B | $-503.00K | $-2.75B | $-33.21M | 3 month · $9.26M 6 month · $13.72M | (m) | (m) |
| 2026-03-31 | $0.00 | $311.00K | $2.71B | $-147.00K | $-2.70B | $2.37M | 3 month · $4.46M | (m) | (m) |
| 2025-12-31 | $0.00 | $302.00K | $2.70B | $457.00K | $-2.70B | $5.35M | 12 month · $41.67M | (m) | (m) |
| 2025-09-30 | $0.00 | $302.00K | $2.69B | $415.00K | $-2.65B | $36.09M | 3 month · $10.98M 9 month · $32.08M | (m) | (m) |
| 2025-06-30 | $0.00 | $300.00K | $2.68B | $267.00K | $-2.62B | $61.49M | 3 month · $11.89M 6 month · $21.10M | (m) | (m) |
| 2025-03-31 | $0.00 | $300.00K | $2.67B | $381.00K | $-2.58B | $91.64M | 3 month · $9.20M | (m) | (m) |
| 2024-12-31 | $0.00 | $294.00K | $2.65B | $422.00K | $-2.15B | $506.59M | 12 month · $71.04M | (m) | (m) |
| 2024-09-30 | $0.00 | $274.00K | $2.60B | $1.55M | $-2.15B | $453.12M | 3 month · $18.26M 9 month · $55.00M | (m) | (m) |
| 2024-06-30 | $0.00 | $272.00K | $2.58B | $-523.00K | $-2.09B | $492.70M | 3 month · $17.22M 6 month · $36.74M | (m) | (m) |
| 2024-03-31 | $0.00 | $272.00K | $2.57B | $-306.00K | $-1.92B | $649.02M | 3 month · $19.52M | (m) | (m) |
| 2023-12-31 | $0.00 | $268.00K | $2.54B | $219.00K | $-1.84B | $701.30M | 12 month · $72.12M | (m) | (m) |
| 2023-09-30 | $0.00 | $258.00K | $2.52B | $-1.84M | $-1.76B | $763.74M | 3 month · $19.69M 9 month · $55.53M | (m) | (m) |
| 2023-06-30 | $0.00 | $250.00K | $2.33B | $-2.69M | $-1.69B | $642.00M | 3 month · $17.89M 6 month · $35.84M | (m) | (m) |
| 2023-03-31 | $0.00 | $250.00K | $2.31B | $-1.92M | $-1.62B | $692.12M | 3 month · $17.95M | (m) | (m) |
| 2022-12-31 | $0.00 | $227.00K | $2.10B | $-4.76M | $-1.53B | $562.90M | 12 month · $78.61M | (m) | (m) |
| 2022-09-30 | (m) | $226.00K | $2.08B | $-6.26M | $-1.45B | $626.59M | 3 month · $18.94M 9 month · $60.66M | (m) | (m) |
| 2022-06-30 | (m) | $225.00K | $2.06B | $-5.46M | $-1.37B | $681.89M | 3 month · $19.23M 6 month · $41.72M | (m) | (m) |
| 2022-03-31 | (m) | $224.00K | $2.04B | $-4.08M | $-1.30B | $734.58M | 3 month · $22.50M | (m) | (m) |
| 2021-12-31 | (m) | $221.00K | $2.01B | $-1.09M | $-1.22B | $790.99M | 12 month · $73.36M | (m) | (m) |
| 2021-09-30 | (m) | $221.00K | $1.99B | $27.00K | $-1.15B | $840.81M | 3 month · $28.45M 9 month · $54.42M | (m) | (m) |
| 2021-06-30 | (m) | $199.00K | $1.42B | $-6.00K | $-1.17B | $258.25M | 3 month · $15.80M 6 month · $25.97M | (m) | (m) |
| 2021-03-31 | (m) | $198.00K | $1.40B | $74.00K | $-1.12B | $280.55M | 3 month · $10.16M | (m) | (m) |
| 2020-12-31 | (m) | $192.00K | $1.37B | $85.00K | $-1.04B | $335.49M | 12 month · $17.53M | (m) | (m) |
| 2020-09-30 | (m) | $180.00K | $1.24B | $118.00K | $-1.11B | $129.50M | 3 month · $4.99M 9 month · $12.26M | (m) | (m) |
| 2020-06-30 | (m) | $154.00K | $1.13B | $243.00K | $-1.09B | $41.39M | 3 month · $3.23M 6 month · $7.27M | (m) | (m) |
| 2020-03-31 | (m) | $154.00K | $1.13B | $30.00K | $-1.07B | $60.40M | 3 month · $4.03M | (m) | (m) |
| 2020-01-01 | (m) | (m) | (m) | (m) | $-1.07B | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $153.00K | $1.12B | $5.00K | $-1.07B | $54.92M | 12 month · $16.40M | (m) | (m) |
| 2019-09-30 | (m) | $153.00K | $1.12B | $11.00K | $-1.07B | $51.01M | 3 month · $4.06M 9 month · $12.53M | (m) | (m) |
| 2019-06-30 | (m) | $153.00K | $1.11B | $17.00K | $-1.04B | $75.75M | 3 month · $4.09M 6 month · $8.47M | (m) | (m) |
| 2019-03-31 | (m) | $153.00K | $1.11B | $6.00K | $-1.01B | $94.85M | 3 month · $4.38M | (m) | (m) |
| 2018-12-31 | (m) | $150.00K | $1.10B | $-36.00K | $-982.11M | $114.06M | 12 month · $23.15M | (m) | (m) |
| 2018-09-30 | (m) | $149.00K | $1.08B | $-24.00K | $-951.31M | $131.88M | 3 month · $5.13M 9 month · $15.63M | (m) | (m) |
| 2018-06-30 | (m) | $132.00K | $1.01B | $-16.00K | $-926.26M | $85.47M | 3 month · $5.22M 6 month · $10.51M | (m) | (m) |
| 2018-03-31 | (m) | $132.00K | $1.01B | $-38.00K | $-903.72M | $102.74M | 3 month · $5.28M | (m) | (m) |
| 2018-01-01 | (m) | (m) | (m) | (m) | $-879.54M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $116.00K | $965.75M | $-32.00K | $-879.73M | $86.10M | 12 month · $20.35M | (m) | (m) |
| 2017-09-30 | (m) | $116.00K | $960.26M | $-2.00K | $-858.97M | $101.41M | (m) | (m) | (m) |
| 2017-06-30 | (m) | $116.00K | $952.71M | $-16.00K | $-836.95M | $115.86M | (m) | (m) | (m) |
| 2017-03-31 | (m) | $94.00K | $880.50M | $-3.00K | $-811.41M | $69.19M | (m) | (m) | (m) |
| 2016-12-31 | (m) | $93.00K | $872.11M | $5.00K | $-787.54M | $84.67M | 12 month · $19.56M | (m) | (m) |
| 2016-09-30 | (m) | $93.00K | $867.08M | $23.00K | $-768.51M | $98.68M | (m) | (m) | (m) |
| 2016-06-30 | (m) | $91.00K | $858.95M | $52.00K | $-751.02M | $108.07M | (m) | (m) | (m) |
| 2016-03-31 | (m) | $87.00K | $821.17M | $41.00K | $-732.52M | $88.78M | (m) | (m) | (m) |
| 2015-12-31 | (m) | $80.00K | $786.64M | $-7.00K | $-713.17M | $73.54M | 12 month · $13.84M | (m) | (m) |
| 2015-09-30 | (m) | $76.00K | $753.05M | $6.00K | $-711.76M | $41.37M | (m) | (m) | (m) |
| 2015-06-30 | (m) | $75.00K | $747.33M | $12.00K | $-713.58M | $33.84M | (m) | (m) | (m) |
| 2015-03-31 | (m) | $75.00K | $742.03M | $16.00K | $-701.65M | $40.47M | (m) | (m) | (m) |
| 2014-12-31 | (m) | $74.00K | $736.34M | $9.00K | $-681.47M | $54.95M | 12 month · $9.94M | (m) | (m) |
| 2014-09-30 | (m) | $71.00K | $715.44M | $23.00K | $-662.50M | $53.03M | (m) | (m) | (m) |
| 2014-06-30 | (m) | $71.00K | $712.24M | $42.00K | $-653.34M | $59.02M | (m) | (m) | (m) |
| 2014-03-31 | (m) | $70.00K | $709.64M | $18.00K | $-634.20M | $75.53M | (m) | (m) | (m) |
| 2013-12-31 | (m) | $66.00K | $684.41M | $14.00K | $-615.31M | $69.18M | 12 month · $9.90M | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | $11.00K | $-598.08M | $83.54M | (m) | (m) | $681.61M |
| 2013-06-30 | (m) | (m) | (m) | $-2.00K | $-577.60M | $100.40M | (m) | (m) | $678.00M |
| 2013-03-31 | (m) | $664.20M | (m) | $11.00K | $-557.12M | $107.09M | (m) | (m) | (m) |
| 2012-12-31 | (m) | $56.00K | $645.32M | $30.00K | $-536.02M | $109.38M | (m) | (m) | $645.37M |
| 2012-09-30 | (m) | $642.82M | (m) | $66.00K | $-514.35M | $128.54M | (m) | (m) | (m) |
| 2012-06-30 | (m) | $639.75M | (m) | $75.00K | $-491.62M | $148.20M | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | $135.00K | $-469.13M | $167.90M | (m) | (m) | (m) |
| 2011-12-31 | (m) | $632.96M | (m) | $57.00K | $-441.56M | $191.46M | 12 month · $780.00K | (m) | (m) |
| 2011-09-30 | (m) | $55.00K | $629.37M | $-4.00K | $-418.73M | $210.68M | (m) | (m) | (m) |
| 2011-06-30 | (m) | $54.00K | $622.54M | $181.00K | $-389.45M | $233.33M | (m) | (m) | (m) |
| 2010-12-31 | (m) | $53.00K | $612.00M | $-21.00K | $-332.17M | $279.87M | 12 month · $428.00K | 12 month · $1.00K | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | $-177.12M | 12 month · $79.00K | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | $-93.39M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |